Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies-Reference-Cited by-同舟云学术

Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies

Published:2024 Issue: Volume: Page:
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Ray Eupa¹²,Jadhav Krishna¹^ORCID,Kadian Monika²,Sharma Garima²,Sharma Kritika²,Jhilta Agrim¹,Singh Raghuraj¹,Kumar Anil²,Verma Rahul Kumar¹^ORCID

Affiliation:

1. Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab, 140306, India

2. University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India

Abstract

Inhalable hybrid nano-assemblies incorporating the tumor homing peptide TMTP1 effectively target and kill tumors, offering a promising therapeutic strategy for advanced small cell lung cancer.

Funder

Science and Engineering Research Board

Indian Council of Medical Research

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D4TB00694A

Reference55 articles.

1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy

3. Management of locally advanced non‐small cell lung cancer: State of the art and future directions

4. Targeted therapy in non-small-cell lung cancer—is it becoming a reality?

5. Prognostic Value of Patient Knowledge of Cancer on Quality of Life in Advanced Lung Cancer During Chemotherapy